Abstract Adult patients on left ventricular assist device (LVAD) support have increased morbidity and mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are no reported clinical data […]
Individuals with Fontan circulation are at risk of late mortality from both cardiac and noncardiac causes. Despite the known risk of mortality, referral indications for advanced heart failure care vary
ACTION Learning Network investigators recently published Ventricular Assist Device Outcomes in Infants and Children With Stage 1 Single Ventricle Palliation in the November 2022 issue of the ASAIO Journal. Examining
The data on the use and outcomes of VADs in children is limited, specifically for those with end-stage heart failure due to an acquired heart disease. Because of this, studies
"*" indicates required fields
Copyright © 2024 Advanced Cardiac Therapies Improving Outcomes Network
